Kainos Medicine Inc (284620) — Strategic Asset Allocation Index
Kainos Medicine Inc (284620) has a Strategic Asset Allocation Index of 8.5% as of March 2025. Strategic assets (PP&E of ₩456.62 Million plus long-term investments of ₩-) total ₩456.62 Million, measured against net assets of ₩5.40 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Kainos Medicine Inc Strategic Asset Allocation Index (2020–2024)
This chart shows how Kainos Medicine Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2020 to 2024. As of March 2025, the index stands at 8.5%, representing strategic assets of ₩456.62 Million against net assets of ₩5.40 Billion KRW. Explore 284620 operating cash flow to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Kainos Medicine Inc (2020–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Kainos Medicine Inc from 2020 to 2024, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 284620 market cap.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 33.7% | ₩602.75 Million | ₩602.75 Million | ₩- | ₩1.79 Billion | ▲ +26.3 pp |
| 2023 | 7.5% | ₩875.47 Million | ₩875.47 Million | ₩- | ₩11.75 Billion | ▼ -13.4 pp |
| 2022 | 20.8% | ₩5.44 Billion | ₩5.44 Billion | ₩- | ₩26.11 Billion | ▼ -6.7 pp |
| 2021 | 27.5% | ₩3.33 Billion | ₩3.33 Billion | ₩- | ₩12.10 Billion | ▲ +12.6 pp |
| 2020 | 15.0% | ₩1.85 Billion | ₩1.85 Billion | ₩- | ₩12.35 Billion | — |